Blood Culture Tests Market - Global Outlook & Forecast 2024-2029

List of Tables

The global blood culture tests market is expected to grow at a CAGR of 7.81% from 2023 to 2029.

MARKET OPPORTUNITIES & TRENDS

Rising Development with Automated Blood Culture Test Systems

The automated blood culture test systems are a ray of hope in the blood culture tests market to increase the speed of diagnosis and reduce contamination rate. With the rising demand for rapid diagnosis of blood-associated and other infectious diseases, the requirement for advanced blood culture test systems is rapidly increasing across the market. These advanced systems are intended to make blood culture processing more efficient and streamlined, as stated by the National Library of Medicine Report 2021. Also, these systems reduce the demand for terminal or blind subculture bottles and increase the speed of test procedures. These systems are effective and efficient and increase blood culture test specificity and sensitivity; these factors are expected to deliver new market growth opportunities.

Advances in Blood Culture Testing

The development and innovation of new technologies for blood culture testing are accelerating the blood culture tests market growth. Bloodstream diseases are a significant cause of severe health outcomes and death with growing incidence and severity. A general blood culture test is the standard method; however, the upcoming new technologies and advances, such as molecular-based diagnostics, are used as add-on complementary assays. It increases test speed and speed-up microbial detection and guesses antimicrobial susceptibility. Furthermore, innovations for blood culture testing, such as molecular testing technologies, are more accurate and sensitive than traditional methods. In the past few years, diagnosing bloodstream infections has relied on time-consuming basic blood cultures and traditional organism identification and susceptibility testing. Technologies to define the culprit in bloodstream infections have gained sophistication in recent years, notably by applying molecular diagnostic methods.

Growing Demand for Early & Preventive Diagnosis

Globally, the rising concern about health drives the demand for early disease diagnosis, positively influencing the blood culture tests market growth. The accurate and early diagnosis of diseases is essential to prevent wasting patients' valuable time on the wrong course of treatments. When a patient gets an accurate diagnosis, it offers the best opportunities for positive health outcomes with the help of clinical decisions tailored to a correct understanding of the patient's health issues. Bloodstream infections, specifically sepsis, are highly demanded for early and preventive diagnosis. Several government initiatives and healthcare policies favor early sepsis and other bloodstream infections. Also, the growing importance of accurate diagnosis is the leading factor accelerating the preference for blood culture tests in infectious disease management. Medical errors are one of the leading causes of death worldwide and were one of the leading causes of death in the U.S. in the past few years. The growing importance of accurate diagnosis of infectious diseases is accelerating visits to clinical laboratories and boosting the demand for blood culture tests and associated equipment and consumables.

SEGMENTATION INSIGHTS

INSIGHTS BY SAMPLE TYPE

The global blood culture tests market by sample type is segmented into bacterial and non-bacterial samples. During the forecast period, the bacterial sample type segment accounted for the highest market share and dominated the market. Bacterial pathogens are significantly prevalent in bloodstream infections compared to other pathogens. Bacterial pathogens severely impact human health and drive the demand for early and preventive diagnosis, where the bacterial sample is commonly used in blood culture testing and accelerates segmental growth.

Segmentation by Sample Type

Bacterial Sample
Non-bacterial Sample

INSIGHTS BY METHOD

The global blood culture tests market by method is segmented into manual/conventional blood culture and automated blood culture. Manual/conventional blood culture methods are traditional and familiar to lab operators. These methods are used longer, giving them high popularity and acceptance. In 2023, the manual/conventional blood culture method segment accounted for the largest share of the market. Manual/conventional blood culture methods are commonly used due to the convenience and affordability of required solutions. Conversely, automated blood culture methods are becoming more popular in recent years. The automation in sample processing gives high efficacy, resulting in the best delivery result. Also, automated blood culture systems are becoming more popular and the primary choice to identify pathogens from blood samples. Rather than manually reading broth-based conventional methods, labs now use continuously monitored automated systems to process blood culture samples.

Segmentation by Method

Manual/Conventional Blood Culture
Automated Blood Culture

INSIGHTS BY PRODUCT

The consumables product segment holds the most significant share of the global blood culture tests market 2023. Consumables are in high demand due to their repetitive use in blood culture testing at all diagnostic laboratories and research centers. Also, some consumables can be used only once and must be discarded or replaced after some time. It increases the application rate and demand for consumables over test equipment. Further, the consumables include a range of solutions used in general to standard laboratories, which include reagents, filters, tubes, plates, and gloves. These consumables are commonly in demand in hospitals, life sciences, academic laboratories, etc.

Segmentation by Product

Consumables
Test Equipment

INSIGHTS BY END-USERS

The global blood culture tests market by end-users is segmented into hospital-based laboratories, clinical laboratories, academic and research laboratories/centers, and others. The hospital-based laboratories segment accounted for over 45% of the highest market share in 2023. Blood culture tests are commonly performed in hospital-associated laboratory centers due to a significant patient population with infectious diseases and a higher prevalence of bloodstream infection in hospital settings. Hospital-acquired infections and associated risks commonly require blood culture tests and significantly contribute to segmental revenue growth.

Segmentation by End-users

Hospital-based Laboratories
Clinical Laboratories
Academic & Research Laboratories/Centers
Others

GEOGRAPHICAL ANALYSIS

North America holds the largest share of the global blood culture tests market, accounting for a global revenue share of 35% in 2023. The region holds a significant market share due to the increasing burden of bloodstream infection across hospital settings, the rising burden of sepsis management, and the growing awareness and acceptance of automated blood culture systems. In addition, the presence of major market players in the U.S. accelerates the influencing demand and adoption of blood culture test equipment and consumables, fueling market growth.

APAC is expected to witness the highest CAGR in the global blood culture tests market during the forecast period. The market growth in APAC is anticipated with the increasing burden of infectious diseases, such as bloodstream infection, sepsis, hospital-associated infection, and others. In addition, the rapid development in healthcare and life sciences is accelerating market growth. China and India are the two leading countries that have witnessed increasing development in the diagnostics field for preventive measures, and early diagnosis of infectious diseases is expected to drive significant market growth in these countries.

Segmentation by Geography

North America
- The U.S.
- Canada
Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Russia
- Poland
APAC
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE

VENDOR LANDSCAPE

Vendors can understand that the traditional blood culture test methods are the most used method over automated blood culture systems, where the automated systems are becoming a new ray of hope in the blood culture tests market. Vendors can develop advanced automated blood culture systems and achieve revenue growth opportunities. Furthermore, globally, bloodstream infection (BSI) and sepsis cases are most commonly reported in healthcare settings, where the demand for blood culture tests is continuously rising and is expected to deliver huge revenue growth opportunities.

Very few automated blood culture test systems are available, and their acceptance is rising steadily in the market, which is a significant opportunity for vendors to develop new solutions. Also, there has been a slow shift from manual to automated blood culture test methods, where vendors can focus on increasing their market penetration by launching new automated systems.

Key Company Profiles

BD
BIOMERIEUX
Bruker
Danaher
Terumo Corporation
Thermo Fisher Scientific

Other Prominent Vendors

Abbott
Autobio
Axiom
Biolab Scientific
Cardinal Health
DiaSorin S.p.A.
F. Hoffmann-La Roche
Hardy Diagnostics
HiMedia Laboratories
ITL BioMedical
Kurin Inc
Labotronics Scientific
Meditech Technologies India Private Limited
OpGen
Render Biotech Co., Ltd.
SARSTEDT AG & Co KG
Siemens Healthineers AG
Scenker Biological Technology Co., Ltd
T2 Biosystems (T2Bio)

KEY QUESTIONS ANSWERED:

1.How big is the blood culture tests market?

2.Which region dominates the global blood culture tests market share?

3.What are the significant trends in the blood culture tests market?

4.What is the growth rate of the global blood culture tests market?

5.Who are the global blood culture test market's key players?

Product Code: ARZ240423

1 SCOPE & COVERAGE

1.1. MARKET DEFINITION
- 1.1.1. INCLUSIONS
- 1.1.2. EXCLUSIONS
- 1.1.3. MARKET ESTIMATION CAVEATS
1.2. SEGMENTS COVERED & DEFINITION
- 1.2.1. MARKET BY SAMPLE TYPE
- 1.2.2. MARKET BY METHOD
- 1.2.3. MARKET BY PRODUCT
- 1.2.4. MARKET BY END-USER
- 1.2.5. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
- 1.3.1. HISTORIC, BASE, & FORECAST YEARS

2 PREMIUM INSIGHTS

2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
- 2.2.1. MARKET OPPORTUNITIES & TRENDS
- 2.2.2. MARKET DRIVERS/ENABLERS
- 2.2.3. MARKET SEGMENTATION
- 2.2.4. MARKET INSIGHTS

3 MARKET AT A GLANCE

4 INTRODUCTION

4.1. OVERVIEW

5 MARKET OPPORTUNITIES & TRENDS

5.1. GROWTH & DEVELOPMENT IN BLOOD CULTURE PATHWAY
5.2. RISING DEVELOPMENT WITH AUTOMATED BLOOD CULTURE TEST SYSTEMS
5.3. ADVANCES IN BLOOD CULTURE TESTING

6 MARKET GROWTH ENABLERS

6.1 INCREASE IN PREVALENCE OF SEPSIS
6.2 RISE IN BURDEN OF BLOODSTREAM INFECTIONS
6.3 INCREASE IN DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS

7 MARKET RESTRAINTS

7.1 CONTAMINATION IS MAJOR CHALLENGE FOR BLOOD CULTURE TESTS
7.2 FALSE POSITIVE & NEGATIVE ERRORS AND ASSOCIATED IMPACTS
7.3 ALTERNATIVES TO BLOOD CULTURE TESTS

8 MARKET LANDSCAPE

8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
- 8.2.1. MARKET BY SAMPLE TYPE
- 8.2.2. MARKET BY METHOD
- 8.2.3. MARKET BY PRODUCT
- 8.2.4. MARKET BY END-USER
- 8.2.5. MARKET BY GEOGRAPHY
8.3. FIVE FORCES ANALYSIS
- 8.3.1. THREAT OF NEW ENTRANTS
- 8.3.2. BARGAINING POWER OF SUPPLIERS
- 8.3.3. BARGAINING POWER OF BUYERS
- 8.3.4. THREAT OF SUBSTITUTES
- 8.3.5. COMPETITIVE RIVALRY

9 SAMPLE TYPE

9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. BACTERIAL SAMPLE
- 9.3.1. MARKET OVERVIEW
- 9.3.2. MARKET SIZE & FORECAST
- 9.3.3. MARKET BY GEOGRAPHY
9.4. NON-BACTERIAL SAMPLE
- 9.4.1. MARKET OVERVIEW
- 9.4.2. MARKET SIZE & FORECAST
- 9.4.3. MARKET BY GEOGRAPHY

10 METHOD

10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. MANUAL/CONVENTIONAL BLOOD CULTURE
- 10.3.1. MARKET OVERVIEW
- 10.3.2. MARKET SIZE & FORECAST
- 10.3.3. MARKET BY GEOGRAPHY
10.4. AUTOMATED BLOOD CULTURE
- 10.4.1. MARKET OVERVIEW
- 10.4.2. MARKET SIZE & FORECAST
- 10.4.3. MARKET BY GEOGRAPHY

11 PRODUCT

11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. CONSUMABLES
- 11.3.1. MARKET OVERVIEW
- 11.3.2. MARKET SIZE & FORECAST
- 11.3.3. MARKET BY GEOGRAPHY
11.4. TEST EQUIPMENT
- 11.4.1. MARKET OVERVIEW
- 11.4.2. MARKET SIZE & FORECAST
- 11.4.3. MARKET BY GEOGRAPHY

12 END-USER

12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. MARKET OVERVIEW
12.3. HOSPITAL-BASED LABORATORIES
- 12.3.1. MARKET OVERVIEW
- 12.3.2. MARKET SIZE & FORECAST
- 12.3.3. MARKET BY GEOGRAPHY
12.4. CLINICAL LABORATORIES
- 12.4.1. MARKET OVERVIEW
- 12.4.2. MARKET SIZE & FORECAST
- 12.4.3. MARKET BY GEOGRAPHY
12.5. ACADEMIC & RESEARCH LABORATORIES/CENTERS
- 12.5.1. MARKET OVERVIEW
- 12.5.2. MARKET SIZE & FORECAST
- 12.5.3. MARKET BY GEOGRAPHY
12.6. OTHERS
- 12.6.1. MARKET OVERVIEW
- 12.6.2. MARKET SIZE & FORECAST
- 12.6.3. MARKET BY GEOGRAPHY

13 GEOGRAPHY

13.1. MARKET SNAPSHOT & GROWTH ENGINE
13.2. GEOGRAPHIC OVERVIEW

14 NORTH AMERICA

14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.3. SAMPLE TYPE
- 14.3.1. MARKET SIZE & FORECAST
14.4. METHOD
- 14.4.1. MARKET SIZE & FORECAST
14.5. PRODUCT
- 14.5.1. MARKET SIZE & FORECAST
14.6. END-USER
- 14.6.1. MARKET SIZE & FORECAST
14.7. KEY COUNTRIES
- 14.7.1. US: MARKET SIZE & FORECAST
- 14.7.2. CANADA: MARKET SIZE & FORECAST

15 EUROPE

15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.3. SAMPLE TYPE
- 15.3.1. MARKET SIZE & FORECAST
15.4. METHOD
- 15.4.1. MARKET SIZE & FORECAST
15.5. PRODUCT
- 15.5.1. MARKET SIZE & FORECAST
15.6. END-USER
- 15.6.1. MARKET SIZE & FORECAST
15.7. KEY COUNTRIES
- 15.7.1. GERMANY: MARKET SIZE & FORECAST
- 15.7.2. FRANCE: MARKET SIZE & FORECAST
- 15.7.3. UK: MARKET SIZE & FORECAST
- 15.7.4. ITALY: MARKET SIZE & FORECAST
- 15.7.5. SPAIN: MARKET SIZE & FORECAST
- 15.7.6. RUSSIA: MARKET SIZE & FORECAST
- 15.7.7. POLAND: MARKET SIZE & FORECAST

16 APAC

16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.3. SAMPLE TYPE
- 16.3.1. MARKET SIZE & FORECAST
16.4. METHOD
- 16.4.1. MARKET SIZE & FORECAST
16.5. PRODUCT
- 16.5.1. MARKET SIZE & FORECAST
16.6. END-USER
- 16.6.1. MARKET SIZE & FORECAST
16.7. KEY COUNTRIES
- 16.7.1. CHINA: MARKET SIZE & FORECAST
- 16.7.2. INDIA: MARKET SIZE & FORECAST
- 16.7.3. JAPAN: MARKET SIZE & FORECAST
- 16.7.4. SOUTH KOREA: MARKET SIZE & FORECAST
- 16.7.5. AUSTRALIA: MARKET SIZE & FORECAST
- 16.7.6. INDONESIA: MARKET SIZE & FORECAST

17 LATIN AMERICA

17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.3. SAMPLE TYPE
- 17.3.1. MARKET SIZE & FORECAST
17.4. METHOD
- 17.4.1. MARKET SIZE & FORECAST
17.5. PRODUCT
- 17.5.1. MARKET SIZE & FORECAST
17.6. END-USER
- 17.6.1. MARKET SIZE & FORECAST
17.7. KEY COUNTRIES
- 17.7.1. BRAZIL: MARKET SIZE & FORECAST
- 17.7.2. MEXICO: MARKET SIZE & FORECAST
- 17.7.3. ARGENTINA: MARKET SIZE & FORECAST

18 MIDDLE EAST & AFRICA

18.1. MARKET OVERVIEW
18.2. MARKET SIZE & FORECAST
18.3. SAMPLE TYPE
- 18.3.1. MARKET SIZE & FORECAST
18.4. METHOD
- 18.4.1. MARKET SIZE & FORECAST
18.5. PRODUCT
- 18.5.1. MARKET SIZE & FORECAST
18.6. END-USER
- 18.6.1. MARKET SIZE & FORECAST
18.7. KEY COUNTRIES
- 18.7.1. TURKEY: MARKET SIZE & FORECAST
- 18.7.2. SAUDI ARABIA: MARKET SIZE & FORECAST
- 18.7.3. SOUTH AFRICA: MARKET SIZE & FORECAST
- 18.7.4. UAE: MARKET SIZE & FORECAST

19 COMPETITIVE LANDSCAPE

19.1. COMPETITION OVERVIEW
19.2. MARKET SHARE ANALYSIS
- 19.2.1. BD
- 19.2.2. BIOMERIEUX
- 19.2.3. BRUKER
- 19.2.4. DANAHER
- 19.2.5. TERUMO CORPORATION
- 19.2.6. THERMO FISHER SCIENTIFIC

20 KEY COMPANY PROFILES

20.1. BD
- 20.1.1. BUSINESS OVERVIEW
- 20.1.2. PRODUCT OFFERINGS
- 20.1.3. KEY STRATEGIES
- 20.1.4. KEY STRENGTHS
- 20.1.5. KEY OPPORTUNITIES
20.2. BIOMERIEUX
- 20.2.1. BUSINESS OVERVIEW
- 20.2.2. PRODUCT OFFERINGS
- 20.2.3. KEY STRATEGIES
- 20.2.4. KEY STRENGTHS
- 20.2.5. KEY OPPORTUNITIES
20.3. BRUKER
- 20.3.1. BUSINESS OVERVIEW
- 20.3.2. PRODUCT OFFERINGS
- 20.3.3. KEY STRATEGIES
- 20.3.4. KEY STRENGTHS
- 20.3.5. KEY OPPORTUNITIES
20.4. DANAHER
- 20.4.1. BUSINESS OVERVIEW
- 20.4.2. PRODUCT OFFERINGS
- 20.4.3. KEY STRATEGIES
- 20.4.4. KEY STRENGTHS
- 20.4.5. KEY OPPORTUNITIES
20.5. TERUMO CORPORATION
- 20.5.1. BUSINESS OVERVIEW
- 20.5.2. PRODUCT OFFERINGS
- 20.5.3. KEY STRATEGIES
- 20.5.4. KEY STRENGTHS
- 20.5.5. KEY OPPORTUNITIES
20.6. THERMO FISHER SCIENTIFIC
- 20.6.1. BUSINESS OVERVIEW
- 20.6.2. PRODUCT OFFERINGS
- 20.6.3. KEY STRATEGIES
- 20.6.4. KEY STRENGTHS
- 20.6.5. KEY OPPORTUNITIES

21 OTHER PROMINENT VENDORS

21.1. ABBOTT
- 21.1.1. BUSINESS OVERVIEW
- 21.1.2. PRODUCT OFFERINGS
21.2. AUTOBIO
- 21.2.1. BUSINESS OVERVIEW
- 21.2.2. PRODUCT OFFERINGS
21.3. AXIOM
- 21.3.1. BUSINESS OVERVIEW
- 21.3.2. PRODUCT OFFERINGS
21.4. BIOLAB SCIENTIFIC
- 21.4.1. BUSINESS OVERVIEW
- 21.4.2. PRODUCT OFFERINGS
21.5. CARDINAL HEALTH
- 21.5.1. BUSINESS OVERVIEW
- 21.5.2. PRODUCT OFFERINGS
21.6. DIASORIN S.P.A.
- 21.6.1. BUSINESS OVERVIEW
- 21.6.2. PRODUCT OFFERINGS
21.7. F. HOFFMANN-LA ROCHE
- 21.7.1. BUSINESS OVERVIEW
- 21.7.2. PRODUCT OFFERINGS
21.8. HARDY DIAGNOSTICS
- 21.8.1. BUSINESS OVERVIEW
- 21.8.2. PRODUCT OFFERINGS
21.9. HIMEDIA LABORATORIES
- 21.9.1. BUSINESS OVERVIEW
- 21.9.2. PRODUCT OFFERINGS
21.10. ITL BIOMEDICAL
- 21.10.1. BUSINESS OVERVIEW
- 21.10.2. PRODUCT OFFERINGS
21.11. KURIN INC
- 21.11.1. BUSINESS OVERVIEW
- 21.11.2. PRODUCT OFFERINGS
21.12. LABOTRONICS SCIENTIFIC
- 21.12.1. BUSINESS OVERVIEW
- 21.12.2. PRODUCT OFFERINGS
21.13. MEDITEC TECHNOLOGIES INDIA PRIVATE LIMITED
- 21.13.1. BUSINESS OVERVIEW
- 21.13.2. PRODUCT OFFERINGS
21.14. OPGEN
- 21.14.1. BUSINESS OVERVIEW
- 21.14.2. PRODUCT OFFERINGS
21.15. RENDER BIOTECH CO., LTD
- 21.15.1. BUSINESS OVERVIEW
- 21.15.2. PRODUCT OFFERINGS
21.16. SARSTEDT AG & CO KG
- 21.16.1. BUSINESS OVERVIEW
- 21.16.2. PRODUCT OFFERINGS
21.17. SIEMENS HEALTHINEERS AG
- 21.17.1. BUSINESS OVERVIEW
- 21.17.2. PRODUCT OFFERINGS
21.18. SCENKER BIOLOGICAL TECHNOLOGY CO., LTD
- 21.18.1. BUSINESS OVERVIEW
- 21.18.2. PRODUCT OFFERINGS
21.19. T2 BIOSYSTEMS (T2BIO)
- 21.19.1. BUSINESS OVERVIEW
- 21.19.2. PRODUCT OFFERINGS

22 REPORT SUMMARY

22.1. KEY TAKEAWAYS
22.2. STRATEGIC RECOMMENDATIONS

23 QUANTITATIVE SUMMARY

23.1. MARKET BY SAMPLE TYPE
23.2. MARKET BY METHOD
23.3. MARKET BY PRODUCT
23.4. MARKET BY END-USER
23.5. MARKET BY GEOGRAPHY
23.6. SAMPLE TYPE: MARKET BY GEOGRAPHY
- 23.6.1. BACTERIAL SAMPLE: MARKET BY GEOGRAPHY
- 23.6.2. NON-BACTERIAL SAMPLE: MARKET BY GEOGRAPHY
23.7. METHOD: MARKET BY GEOGRAPHY
- 23.7.1. MANUAL/CONVENTIONAL BLOOD CULTURE: MARKET BY GEOGRAPHY
- 23.7.2. AUTOMATED BLOOD CULTURE: MARKET BY GEOGRAPHY
23.8. PRODUCT: MARKET BY GEOGRAPHY
- 23.8.1. CONSUMABLES: MARKET BY GEOGRAPHY
- 23.8.2. TEST EQUIPMENT: MARKET BY GEOGRAPHY
23.9. END-USER: MARKET BY GEOGRAPHY
- 23.9.1. HOSPITAL-BASED LABORATORIES: MARKET BY GEOGRAPHY
- 23.9.2. CLINICAL LABORATORIES: MARKET BY GEOGRAPHY
- 23.9.3. ACADEMIC & RESEARCH LABORATORIES/CENTERS: MARKET BY GEOGRAPHY
- 23.9.4. OTHERS: MARKET BY GEOGRAPHY

24 APPENDIX

24.1. RESEARCH METHODOLOGY
24.2. RESEARCH PROCESS
24.3. REPORT ASSUMPTIONS & CAVEATS
- 24.3.1. KEY CAVEATS
- 24.3.2. CURRENCY CONVERSION
24.4. ABBREVIATIONS